Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
ACHIEVE-5 (NCT06109311) A placebo-controlled trial in type 2 diabetes, complementing the active comparator studies by providing clean placebo-adjusted efficacy estimates
Parmar RS et al
Anti-sympathetic drugs, such as -blockers, may represent suitable candidates in combination with DPP-4 for the treatment of hypertension with which to prevent sympathetic activity
Ai-Ping Wang for critical reading of the manuscript and Editage (www.editage.cn) for English language editing
Whether due to a demanding lifestyle, poor dietary habits, or specific health conditions, this IV therapy provides a direct and efficient route for nutrient absorption, ensuring rapid and effective replenishment
Manage RISK score: Please note SIGN guideline recommend FPG range 6.1 -6.9 in line with WHO guidelines
US$ 22.88
US$ 25.95
US$ 19.98
US$ 21.16
US$ 22.88
US$ 26.52
US$ 28.95
US$ 25.97
US$ 24.35
US$ 25.48
US$ 26.87
US$ 23.33
US$ 20.64
US$ 27.95
US$ 29.56
US$ 22.76
